Health Catalyst, Inc. (NASDAQ:HCAT) Short Interest Up 24.1% in March

Health Catalyst, Inc. (NASDAQ:HCAT) saw a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 2,940,000 shares, an increase of 24.1% from the February 28th total of 2,370,000 shares. Approximately 5.0% of the company’s stock are sold short. Based on an average daily volume of 807,300 shares, the days-to-cover ratio is currently 3.6 days.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on HCAT shares. KeyCorp upgraded shares of Health Catalyst from a “sector weight” rating to an “overweight” rating and set a $9.00 target price on the stock in a research note on Wednesday, January 8th. Piper Sandler decreased their price target on shares of Health Catalyst from $12.00 to $8.00 and set an “overweight” rating for the company in a report on Tuesday, February 11th. Royal Bank of Canada dropped their price objective on Health Catalyst from $7.00 to $6.00 and set a “sector perform” rating on the stock in a research note on Thursday, February 27th. Canaccord Genuity Group cut their price objective on Health Catalyst from $11.00 to $10.00 and set a “buy” rating for the company in a research report on Tuesday, January 21st. Finally, Wells Fargo & Company lowered their target price on Health Catalyst from $13.00 to $10.00 and set an “overweight” rating on the stock in a report on Tuesday, January 21st. Three investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $9.27.

Health Catalyst Stock Performance

Health Catalyst stock traded down $0.04 during trading hours on Tuesday, hitting $4.50. The stock had a trading volume of 289,662 shares, compared to its average volume of 613,499. The company has a 50-day moving average of $5.01 and a two-hundred day moving average of $6.83. The company has a quick ratio of 1.41, a current ratio of 1.41 and a debt-to-equity ratio of 0.32. Health Catalyst has a fifty-two week low of $3.76 and a fifty-two week high of $9.24. The company has a market cap of $315.60 million, a PE ratio of -3.34 and a beta of 1.41.

Insider Transactions at Health Catalyst

In other news, COO Daniel Lesueur sold 5,209 shares of the stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $7.51, for a total transaction of $39,119.59. Following the transaction, the chief operating officer now owns 91,253 shares of the company’s stock, valued at approximately $685,310.03. This represents a 5.40 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Linda Llewelyn sold 6,442 shares of the firm’s stock in a transaction that occurred on Wednesday, January 15th. The shares were sold at an average price of $5.80, for a total value of $37,363.60. Following the completion of the transaction, the insider now directly owns 92,260 shares in the company, valued at $535,108. The trade was a 6.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 56,530 shares of company stock worth $299,572 in the last 90 days. 2.50% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of HCAT. Quantbot Technologies LP acquired a new stake in Health Catalyst during the fourth quarter worth $29,000. Group One Trading LLC lifted its holdings in shares of Health Catalyst by 107.6% during the 4th quarter. Group One Trading LLC now owns 4,360 shares of the company’s stock worth $31,000 after acquiring an additional 2,260 shares during the period. Quest Partners LLC acquired a new stake in shares of Health Catalyst during the 3rd quarter valued at about $34,000. Aquatic Capital Management LLC bought a new stake in Health Catalyst in the fourth quarter valued at about $63,000. Finally, Stoneridge Investment Partners LLC bought a new stake in Health Catalyst in the fourth quarter valued at about $77,000. 85.00% of the stock is currently owned by institutional investors and hedge funds.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.